Insider Transactions in Q3 2025 at Angiodynamics Inc (ANGO)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2025
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.43%
|
$3,160
$8.99 P/Share
|
|
Jul 21
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.39%
|
$2,216
$8.99 P/Share
|
|
Jul 21
2025
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
667
-0.26%
|
$5,336
$8.99 P/Share
|
|
Jul 20
2025
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-0.39%
|
$2,872
$8.69 P/Share
|
|
Jul 20
2025
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,655
-0.38%
|
$53,240
$8.84 P/Share
|
|
Jul 20
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-0.36%
|
$2,008
$8.69 P/Share
|
|
Jul 20
2025
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-0.91%
|
$4,928
$8.69 P/Share
|
|
Jul 20
2025
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-0.28%
|
$5,736
$8.69 P/Share
|
|
Jul 19
2025
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-1.09%
|
$8,200
$8.69 P/Share
|
|
Jul 19
2025
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,651
-0.49%
|
$69,208
$8.69 P/Share
|
|
Jul 19
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
735
-1.03%
|
$5,880
$8.69 P/Share
|
|
Jul 19
2025
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-2.86%
|
$15,864
$8.69 P/Share
|
|
Jul 19
2025
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,585
-1.0%
|
$20,680
$8.69 P/Share
|
|
Jul 17
2025
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
3,074
-4.24%
|
$24,592
$8.74 P/Share
|
|
Jul 16
2025
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+10.96%
|
-
|
|
Jul 16
2025
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+16.35%
|
-
|
|
Jul 16
2025
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+14.4%
|
-
|
|
Jul 16
2025
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+17.49%
|
-
|
|
Jul 16
2025
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+14.44%
|
-
|
|
Jul 16
2025
|
Lorinda Burgess |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+24.23%
|
-
|
|
Jul 16
2025
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
32,423
+30.92%
|
-
|
|
Jul 16
2025
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+9.57%
|
-
|
|
Jul 16
2025
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
26,268
+21.83%
|
-
|
|
Jul 16
2025
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
86,997
+25.09%
|
-
|
|
Jul 16
2025
|
Lawrence T Weiss SVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,900
+26.99%
|
-
|
|
Jul 16
2025
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
206,253
+18.85%
|
-
|
|
Jul 16
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
29,349
+29.2%
|
-
|